CLINICAL_TRIALS
trial_result
· 2026-02-11
Clinical Trial Update: Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY) [Phase 3]
Summary
Phase 3 MODERATO STUDY evaluating atropine eyedrops to slow myopia progression in children and adolescents is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ocus Innovation Ireland Limited | Conditions: Myopia | Phase 3 | Status: RECRUITING